Registration
 
All news
Top Stories
Editors' Picks
Stocks
Crypto
Economics
Currencies
Commodities
Business & Wealth
Market Voices
Viktoras Karapetjanc
Viktoras Karapetjanc

Eli Lilly presents positive one-year results for ulcerative colitis: Can LLY break above $1,275?

Eli Lilly presents positive one-year results for ulcerative colitis: Can LLY break above $1,275?
Eli Lilly stock edges higher today

Eli Lilly presented one-year Phase 3 data in children and adolescents with ulcerative colitis at UEGWeek, reporting positive results from its SHINE-2 study. Shares edge higher on the day, trading at $1,257.

LLY price prediction
24H 0.93%
$1,431.26
48H 0.59%
$1,426.42
7D 0.18%
$1,420.57
1M 14.41%
$1,622.48
3M 37.9%
$1,955.5
6M 21.9%
$1,728.67
12M 47.06%
$2,085.44
Detailed
Current price: $1,418.07 8.69 0.62%
Closed 11/04
Daily range 1401.59 Arrow from to Icon 1445.96
Weekly range 1360.97 Arrow from to Icon 1445.96
Loading...

Highlights

  • Eli Lilly reported positive one-year Phase 3 results from the SHINE-2 study in children and adolescents with ulcerative colitis.
  • 96 of 118 analysts rate Eli Lilly stock a buy, with a median price target of $1,385 and a current price of $1,257.
  • The company has a market value near $1,051.6 billion on trailing revenue of $79.66 billion and employs 50,000 people.

Eli Lilly presented late-breaking Phase 3 investigational data from its SHINE-2 study at a UEGWeek congress, indicating positive one-year results for children and adolescents with ulcerative colitis. The SHINE-2 study specifically focused on delivering outcomes for young patients with this condition. The event was originally announced on September 25, 2026.

Bullish structure holds as RSI nears overbought conditions

RSI at 68.6 is nearing overbought territory, indicating the advance may be getting stretched. Shares of Eli Lilly continue to trade within a broadly bullish daily setup, staying above their MA-20, MA-50, and MA-200. The next key resistance is the weekly high at $1,275, which could serve as a hurdle if buyers remain active.

Upside odds remain high as traders watch the weekly resistance

A close above $1,275 would indicate that buyers are willing to follow through on recent gains. RSI at 68.6 suggests upward moves may be losing steam as the rally approaches overbought conditions. Even after a sharp move higher over the past week without a sustained trend, the probabilities for the coming trading week show more than 80% likelihood of further upside and less than 20% chance of downside, with an expected range of $1,205 to $1,309. A drop below $1,194 would show the move is being faded. On the weekly chart the longer-term picture stays firmly constructive.

Previously it was reported that Eli Lilly broke ground on a major new manufacturing facility in Houston as part of a broader expansion strategy. The latest positive clinical data from SHINE-2 further strengthens the company's long-term outlook, with attention now on whether shares can maintain momentum above $1,257 as the trading range shifts higher.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

Top 5 countries where the stock market is worth more than economy
  • By Oleg Tkachenko
  • 1 hour ago
Top 5 countries where the stock market is worth more than economy
Editors' Picks
How China is turning AI credits into Singles’ Day’s newest staple
  • By Dmytro Kharkov
  • 18 hours ago
How China is turning AI credits into Singles’ Day’s newest staple
Editors' Picks
Banks vs. crypto companies: Who better protects your money from hackers?
  • By Elena Nikulina
  • 21 hours ago
Banks vs. crypto companies: Who better protects your money from hackers?
Editors' Picks
All Editors' Top Picks

Latest Eli Lilly News

Eli Lilly announces third-quarter 2026 results: Can LLY break above $1,320?
  • By Dmytro Kharkov
  • 29.10.2026
Eli Lilly announces third-quarter 2026 results: Can LLY break above $1,320?
Companies
#Eli Lilly
Eli Lilly breaks ground on new Goochland facility as stock rises 3.4%
  • By Hlib Chabaniuk
  • 22.10.2026
Eli Lilly breaks ground on new Goochland facility as stock rises 3.4%
Companies
#Eli Lilly
Eli Lilly breaks ground on new Houston manufacturing site as stock edges higher
  • By Aleksandra Chaikina
  • 22.09.2026
Eli Lilly breaks ground on new Houston manufacturing site as stock edges higher
Companies
#Eli Lilly
All Eli Lilly News
  • Oleg Tkachenko
  • 1 hour ago
Top 5 countries where the stock market is worth more than economy
  • Dmytro Kharkov
  • 18 hours ago
How China is turning AI credits into Singles’ Day’s newest staple
  • Elena Nikulina
  • 21 hours ago
Banks vs. crypto companies: Who better protects your money from hackers?
  • Eugene Komchuk
  • Yesterday
U.S. elections: What awaits the crypto industry after the Democrats' victory?
  • Anastasiia Chabaniuk
  • Yesterday
From Coinbase to Visa: Who makes money from blockchain?
  • Elena Nikulina
  • 10 min ago
Base rate expected to rise to 4.00%, markets indicate
  • Yaroslav Dmytrenko
  • 25 min ago
Peter Spina: China crackdown drives wealthy to gold as Hong Kong jewelry sales reach highest since 2019
  • Mikhail Vnuchkov
  • 40 min ago
Samson Mow: Nation-state Bitcoin adoption could reduce impact of systemic banking failures
  • Oksana Koneva
  • 55 min ago
Bank of England rate hike likely due to rising inflation, Mario Nawfal notes
  • Daria Chernytska
  • 1 hour ago
Gracy Chen: OCN asset launches with banking and trading on Bitget
Top News
  • Ivan Andriyenko
  • 12 min ago
Microsoft drops option to double Texas data center capacity with Nscale
Microsoft drops option to double Texas data center capacity with Nscale
  • Olga Shendetskaya
  • 2 hours ago
Gold rises above $4,100 as U.S. dollar weakens after midterms
Gold rises above $4,100 as U.S. dollar weakens after midterms
  • Eugene Komchuk
  • 3 hours ago
Polygon proposes hard fork to recover funds stolen from Binance
Polygon proposes hard fork to recover funds stolen from Binance
  • Oleksii Zaichenko
  • 18 hours ago
Bitcoin tops $80,500 as U.S. stocks rally after midterm elections
Bitcoin tops $80,500 as U.S. stocks rally after midterm elections
  • Dmytro Kharkov
  • 18 hours ago
How China is turning AI credits into Singles’ Day’s newest staple
How China is turning AI credits into Singles’ Day’s newest staple
Live News
  • Andrey Mastykin
  • Now
UBS cuts jobs in London as Credit Suisse merger nears completion
  • Pavlo Kot
  • Now
Trump Media transfers 4,259 BTC to Crypto.com as shares hit record low
  • Mykhailo Ihnatenko
  • Now
Ethereum rebounds after U.S. elections: Can ETF inflows fuel a push to $2,500?
  • Igor Krasulya
  • Now
Demand for Meta debut euro bonds exceeds offering size sixfold
  • Olga Shendetskaya
  • Now
McDonald's reports first sales decline in 18 months
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org https://gdpr.eu/ GDPR World Association of News Publishers